Drugs / Soluble Beta-1,3/1,6-glucan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00804414 | Oct 2008 → Aug 2009 | chronic ulcer of skin, diabetes mellitus | Biotec Pharmacon ASA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soluble Beta-1,3/1,6-glucan | “Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers” NCT00804414 ↗ |
| Known as | SBG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00804414 ↗ |
| Route | Topical | “Solution for topical use” NCT00804414 ↗ |